Karen Peralta Buendía

Mrs. Karen Peralta Buendía


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
KBKaren Peralta Buendía
Karen Peralta Buendía
CCCuevas-Lopez Cuevas-Lopez
Cuevas-Lopez Cuevas-Lopez
FAFernando Garcia Arroyo
Fernando Garcia Arroyo
MDMiriam Díaz-Rojas
Miriam Díaz-Rojas
JUAN CARLOS LEON CONTRERASJUAN CARLOS LEON CONTRERAS
JUAN CARLOS LEON CONTRERAS
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
Chronic kidney disease (CKD) cardiac impairment is manifested as cardio-renal syndrome type 4 (CRS-IV). The kidneys and heart are highly dependent on mitochondria; thus, bioenergetics and redox and biogenesis alterations are critical in CKD and heart damage. Most previous studies have focused on the advanced stage of CRS-IV, but mitochondrial impairment onset in the early stages and its pathological pathways are poorly understood. In this work, we characterized mitochondrial bioenergetics, biogenesis and redox impairment in both tissues in the early stages after CKD and analyzed their relationship with CRS-IV in a CKD model with 5/6 nephrectomy (NX). We found the first cardiac mitochondrial alterations 10 days after surgery, together with an increase in plasma cardio-renal connectors, derived from renal mitochondrial damage. Oxidative phosphorylation capacity decreased and uncoupling led to oxidative stress, inflammation, cardiac hypertrophy and ejection fraction reduction, triggering CRS-IV. N-acetylcysteine (NAC) administration prevented mitochondrial alterations in both organs and heart damage. Interestingly, the protective effects of NAC correlated with SIRT1/3-PGC-1α pathway overactivation. These results suggest that mitochondrial biogenesis induction and redox regulation protection in the early stages after renal damage serve as a strategy to prevent bioenergetic alterations in the kidneys and heart, preventing inflammation and CRS-IV development.